华法林或直接口服抗凝药围手术期中断患者的结局
密歇根抗凝质量改进计划六家抗凝门诊中至少一次因手术中断口服抗凝药的患者纳入分析,采用逆概率治疗加权平衡华法林组与DOAC组基线差异,比较术后30天内出血与血栓栓塞事件。结果显示DOAC组术后轻微出血、大出血及临床相关非大出血发生率均高于未桥接华法林组,而与桥接华法林组相似。
要点
- DOAC组术后轻微出血10.8%高于未桥接华法林组4.7%(p < .001)。
- DOAC组术后大出血2.9%高于未桥接华法林组1.1%(p = .01)。
- DOAC组术后CRNMB 6.5%高于未桥接华法林组3.0%(p = .002)。
核心结论
- 与未桥接华法林相比,围手术期中断DOAC与术后30天轻微出血、大出血及CRNMB发生率更高相关。
研究设计与样本
- 研究纳入密歇根抗凝质量改进计划六家抗凝门诊中至少一次因手术中断口服抗凝药的患者。
- 采用逆概率治疗加权(IPTW)平衡华法林队列与DOAC队列的基线差异。
- 共525例DOAC患者与1323例华法林患者匹配,其中华法林组923例未桥接、400例桥接。
主要发现
- DOAC组术后轻微出血10.8% vs 未桥接华法林组4.7%(p < .001)。
- DOAC组术后大出血2.9% vs 未桥接华法林组1.1%(p = .01)。
- DOAC组术后CRNMB 6.5% vs 未桥接华法林组3.0%(p = .002)。
- DOAC组与桥接华法林组术后出血结局发生率相似。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文结论指出需要进一步研究来探讨这两类抗凝药的围手术期结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Differences in clinical outcomes following a temporary interruption of warfarin or a direct oral anticoagulant (DOAC) for a surgical procedure are not well described. Differences in patient characteristics from practice-based cohorts have not typically been accounted for in prior analyses. AIM: To describe risk-adjusted differences in postoperative outcomes following an interruption of warfarin vs DOACs. METHODS: Patients receiving care at six anticoagulation clinics participating in the Michigan Anticoagulation Quality Improvement Initiative were included if they had at least one oral anticoagulant interruption for a procedure. Inverse probability of treatment weighting (IPTW) was used to balance baseline differences between the warfarin cohort and DOAC cohort. Bleeding and thromboembolic events within 30 days following the procedure were compared between the IPTW cohorts using the Poisson distribution test. RESULTS: A total of 525 DOAC patients were matched with 1323 warfarin patients, of which 923 were nonbridged warfarin patients and 400 were bridged warfarin patients. The occurrence of postoperative minor bleeding (10.8% vs. 4.7%, p < .001), major bleeding (2.9% vs. 1.1%, p = .01) and clinically relevant nonmajor bleeding (CRNMB) (6.5% vs. 3.0%, p = .002) was greater in the DOAC cohort compared with the nonbridged warfarin cohort. The rates of postoperative bleeding outcomes were similar between the DOAC and the bridged warfarin cohorts. CONCLUSION: Perioperative interruption of DOACs, compared with warfarin without bridging, is associated with a higher incidence of 30-day minor bleeds, major bleeds, and CRNMBs. Further research investigating the perioperative outcomes of these two classes of anticoagulants is warranted.
引用
- Lee J, Kong X, Haymart B, et al. Outcomes in patients undergoing periprocedural interruption of warfarin or direct oral anticoagulants. J Thromb Haemost. 2022. PMID: 35962753. doi:10.1111/jth.15850
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。